{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-26-000003","form_type":"8-K","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.337701+00:00","generated_at":"2026-05-16T11:07:31.456618+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Haemonetics acquires Vivasure Medical for up to €185M; upfront €100M plus €85M earn-out","bullets":["Acquired all equity of Vivasure Medical, a Galway, Ireland-based developer of percutaneous vessel closure technology.","Upfront consideration of €100M, net €52M after deducting prior investments and loans.","Up to €85M in contingent consideration tied to sales growth and other milestones.","Transaction funded with available cash on hand."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-26-000003","json":"https://secwatch.observer/filing/0000313143-26-000003.json","markdown":"https://secwatch.observer/filing/0000313143-26-000003.md","text":"https://secwatch.observer/filing/0000313143-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/0000313143-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/hae-20260109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:07:31.456618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}